Acrivon Therapeutics, Inc. (ACRV)
(Delayed Data from NSDQ)
$7.33 USD
-0.23 (-3.04%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $7.33 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.59 | 0.00% |
Earnings Summary
For their last quarter, Acrivon Therapeutics, Inc. (ACRV) reported earnings of -$0.73 per share, beating the Zacks Consensus Estimate of $-0.89 per share. This reflects a positive earnings surprise of 17.98%. Look out for ACRV's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.59 per share, reflecting a year-over-year increase of 6.35%.
Earnings History
Price & Consensus
Zacks News for ACRV
AbbVie (ABBV) Files for Rinvoq in Giant Cell Arteritis in US & EU
ACRV: What are Zacks experts saying now?
Zacks Private Portfolio Services